Cavin1; a Regulator of Lung Function and Macrophage Phenotype

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Govender, Praveen ^a   Romero, Freddy ^b   Shah, Dilip ^b   Paez, Jesus ^a   Ding, Shi Ying ^a   Liu, Libin ^a   Gower, Adam ^a   Baez, Elizabeth ^a   Aly, Sherif Shawky ^a   Pilch, Paul ^a   Summer, Ross ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVIN1 PROTEIN; CXCL2 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PTRF PROTEIN, MOUSE; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HOMEOSTASIS; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG FUNCTION; LUNG STRUCTURE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE SPECIFICITY; ANIMAL; CELL LINE; CYTOLOGY; DEFICIENCY; GENE INACTIVATION; GENETICS; LUNG; MACROPHAGE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CELL LINE; FEMALE; GENE KNOCKOUT TECHNIQUES; HOMEOSTASIS; LUNG; MACROPHAGES; MEMBRANE PROTEINS; MICE; PHENOTYPE; RNA-BINDING PROTEINS;

EID: 84876741554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062045     Document Type: Article

References (47)

1. Gil J, (1983) Number and distribution of plasmalemmal vesicles in the lung. Fed Proc 42: 2414-2418.
2. Razani B, Woodman SE, Lisanti MP, (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467.
3. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. The Journal of biological chemistry 276: 38121-38138.
4. Drab M, Verkade P, Elger M, Kasper M, Lohn M, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452.
5. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, et al. (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22: 2329-2344.
6. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, et al. (2002) Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160: 2207-2217.
7. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, et al. (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. The Journal of biological chemistry 277: 38988-38997.
8. Razani B, Combs TP, Wang XB, Frank PG, Park DS, et al. (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. The Journal of biological chemistry 277: 8635-8647.
9. Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, et al. (2008) Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8: 310-317.
10. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, et al. (2009) Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. The Journal of clinical investigation 119: 2623-2633.
11. Shastry S, Delgado MR, Dirik E, Turkmen M, Agarwal AK, et al. (2010) Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am J Med Genet A 152A: 2245-2253.
12. Le Lay S, Kurzchalia TV, (2005) Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 1746: 322-333.
13. Briand N, Dugail I, Le Lay S, (2011) Cavin proteins: New players in the caveolae field. Biochimie 93: 71-77.
14. Voldstedlund M, Vinten J, Tranum-Jensen J, (2001) cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins. Cell Tissue Res 306: 265-276.
15. Vinten J, Voldstedlund M, Clausen H, Christiansen K, Carlsen J, et al. (2001) A 60-kDa protein abundant in adipocyte caveolae. Cell Tissue Res 305: 99-106.
16. Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I, (1998) Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. Embo J 17: 2855-2864.
17. Vinten J, Johnsen AH, Roepstorff P, Harpoth J, Tranum-Jensen J, (2005) Identification of a major protein on the cytosolic face of caveolae. Biochim Biophys Acta 1717: 34-40.
18. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, et al. (2007) Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. Journal of immunology 178: 8081-8089.
19. Konter JM, Parker JL, Baez E, Li SZ, Ranscht B, et al. (2012) Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation. J Immunol 188: 854-863.
20. Inselman LS, Wapnir RA, Spencer H, (1987) Obesity-induced hyperplastic lung growth. Am Rev Respir Dis 135: 613-616.
21. Summer R, Fiack CA, Ikeda Y, Sato K, Dwyer D, et al. (2009) Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol 297: L432-438.
22. Murphy J, Summer R, Wilson AA, Kotton DN, Fine A, (2008) The prolonged life-span of alveolar macrophages. American journal of respiratory cell and molecular biology 38: 380-385.
23. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
24. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
25. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
26. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
27. University of Michigan Molecular and Behavioral Neuroscience Institute: Microarray Lab.
28. Smyth GK, editor (2005) Limma: linear models for microarray data. In: 'Bioinformatics and Computational Biology Solutions using R and Bioconductor'. New York: Springer.
29. R Development Core Team (2011) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
30. The R Project for Statistical Computing.
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
32. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP, (2007) GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251-3253.
33. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
34. Gosens R, Mutawe M, Martin S, Basu S, Bos ST, et al. (2008) Caveolae and caveolins in the respiratory system. Curr Mol Med 8: 741-753.
35. Cohen AW, Hnasko R, Schubert W, Lisanti MP, (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379.
36. Sharifi BG, Zeng Z, Wang L, Song L, Chen H, et al. (2006) Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol 26: 1273-1280.
37. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, et al. (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81: 557-566.
38. Yang ZF, Poon RT, Luo Y, Cheung CK, Ho DW, et al. (2004) Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. Journal of immunology 173: 2507-2515.
39. Briand N, Le Lay S, Sessa WC, Ferre P, Dugail I, (2011) Distinct roles of endothelial and adipocyte caveolin-1 in macrophage infiltration and adipose tissue metabolic activity. Diabetes 60: 448-453.
40. Gerszten RE, Tager AM, (2012) The monocyte in atherosclerosis-should I stay or should I go now? N Engl J Med 366: 1734-1736.
41. van Gils JM, Derby MC, Fernandes LR, Ramkhelawon B, Ray TD, et al. (2012) The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 13: 136-143.
42. Millan J, Hewlett L, Glyn M, Toomre D, Clark P, et al. (2006) Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 8: 113-123.
43. Torres VA, Tapia JC, Rodriguez DA, Parraga M, Lisboa P, et al. (2006) Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci 119: 1812-1823.
44. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, et al. (2001) Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 12: 2229-2244.
45. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, et al. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
46. Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA, (1996) Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest 97: 649-655.
47. Uchida K, Beck DC, Yamamoto T, Berclaz PY, Abe S, et al. (2007) GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 356: 567-579.